BRAINSWAY LTD-ADR (BWAY) Stock Fundamental Analysis
USA - NASDAQ:BWAY - US10501L1061 - ADR
15.095 USD
-0.67 (-4.25%)
Taking everything into account, BWAY scores 6 out of 10 in our fundamental rating. BWAY was compared to 191 industry peers in the Health Care Equipment & Supplies industry. BWAY is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. An interesting combination arises when we look at growth and value: BWAY is growing strongly while it also seems undervalued. With these ratings, BWAY could be worth investigating further for value and growth investing!.
1. Profitability
1.1 Basic Checks
BWAY had positive earnings in the past year.
In the past year BWAY had a positive cash flow from operations.
BWAY had negative earnings in 4 of the past 5 years.
In multiple years BWAY reported negative operating cash flow during the last 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 3.91%, BWAY belongs to the top of the industry, outperforming 80.10% of the companies in the same industry.
BWAY's Return On Equity of 6.14% is fine compared to the rest of the industry. BWAY outperforms 79.06% of its industry peers.
BWAY has a better Return On Invested Capital (1.90%) than 69.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.91% | ||
| ROE | 6.14% | ||
| ROIC | 1.9% |
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of BWAY (9.01%) is better than 81.68% of its industry peers.
BWAY has a better Operating Margin (4.32%) than 69.11% of its industry peers.
With an excellent Gross Margin value of 74.51%, BWAY belongs to the best of the industry, outperforming 86.91% of the companies in the same industry.
In the last couple of years the Gross Margin of BWAY has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.32% | ||
| PM (TTM) | 9.01% | ||
| GM | 74.51% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
2. Health
2.1 Basic Checks
BWAY has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, BWAY has more shares outstanding
Compared to 5 years ago, BWAY has more shares outstanding
Compared to 1 year ago, BWAY has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 4.71 indicates that BWAY is not in any danger for bankruptcy at the moment.
BWAY's Altman-Z score of 4.71 is fine compared to the rest of the industry. BWAY outperforms 78.01% of its industry peers.
The Debt to FCF ratio of BWAY is 0.69, which is an excellent value as it means it would take BWAY, only 0.69 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of BWAY (0.69) is better than 92.15% of its industry peers.
BWAY has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
BWAY has a better Debt to Equity ratio (0.07) than 64.40% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 0.69 | ||
| Altman-Z | 4.71 |
ROIC/WACC0.22
WACC8.76%
2.3 Liquidity
A Current Ratio of 5.03 indicates that BWAY has no problem at all paying its short term obligations.
BWAY has a Current ratio of 5.03. This is in the better half of the industry: BWAY outperforms 76.44% of its industry peers.
A Quick Ratio of 4.75 indicates that BWAY has no problem at all paying its short term obligations.
BWAY has a better Quick ratio (4.75) than 79.58% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.03 | ||
| Quick Ratio | 4.75 |
3. Growth
3.1 Past
BWAY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1178.38%, which is quite impressive.
BWAY shows a strong growth in Revenue. In the last year, the Revenue has grown by 29.04%.
Measured over the past years, BWAY shows a quite strong growth in Revenue. The Revenue has been growing by 12.17% on average per year.
EPS 1Y (TTM)1178.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%141.89%
Revenue 1Y (TTM)29.04%
Revenue growth 3Y11.41%
Revenue growth 5Y12.17%
Sales Q2Q%21.26%
3.2 Future
BWAY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 54.94% yearly.
BWAY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.29% yearly.
EPS Next Y58.83%
EPS Next 2Y52.73%
EPS Next 3Y54.94%
EPS Next 5YN/A
Revenue Next Year15%
Revenue Next 2Y18.5%
Revenue Next 3Y19.29%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 10.86, which indicates a very decent valuation of BWAY.
BWAY's Price/Earnings ratio is rather cheap when compared to the industry. BWAY is cheaper than 92.15% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.27, BWAY is valued rather cheaply.
With a Price/Forward Earnings ratio of 7.47, the valuation of BWAY can be described as very cheap.
BWAY's Price/Forward Earnings ratio is rather cheap when compared to the industry. BWAY is cheaper than 97.91% of the companies in the same industry.
BWAY's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.77.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.86 | ||
| Fwd PE | 7.47 |
4.2 Price Multiples
64.92% of the companies in the same industry are more expensive than BWAY, based on the Enterprise Value to EBITDA ratio.
BWAY's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. BWAY is cheaper than 78.53% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 35.62 | ||
| EV/EBITDA | 58.9 |
4.3 Compensation for Growth
BWAY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BWAY's earnings are expected to grow with 54.94% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.18
PEG (5Y)N/A
EPS Next 2Y52.73%
EPS Next 3Y54.94%
5. Dividend
5.1 Amount
No dividends for BWAY!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:BWAY (9/15/2025, 8:00:02 PM)
15.095
-0.67 (-4.25%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners5.19%
Inst Owner Change-3.74%
Ins Owners16.69%
Ins Owner ChangeN/A
Market Cap285.32M
Analysts85.71
Price Target0.11 (-99.27%)
Short Float %1.22%
Short Ratio2.94
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)35.29%
Min EPS beat(2)-22.64%
Max EPS beat(2)93.23%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.17%
Min Revenue beat(2)-2.35%
Max Revenue beat(2)0.01%
Revenue beat(4)3
Avg Revenue beat(4)-0.34%
Min Revenue beat(4)-2.35%
Max Revenue beat(4)0.82%
Revenue beat(8)6
Avg Revenue beat(8)1.7%
Revenue beat(12)6
Avg Revenue beat(12)-23.98%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)32.74%
PT rev (3m)44.06%
EPS NQ rev (1m)-0.02%
EPS NQ rev (3m)-0.1%
EPS NY rev (1m)20.25%
EPS NY rev (3m)20.16%
Revenue NQ rev (1m)-24.45%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-1.4%
Revenue NY rev (3m)-3.52%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.86 | ||
| Fwd PE | 7.47 | ||
| P/S | 6.57 | ||
| P/FCF | 35.62 | ||
| P/OCF | 23.53 | ||
| P/B | 4.48 | ||
| P/tB | 4.48 | ||
| EV/EBITDA | 58.9 |
EPS(TTM)1.39
EY9.21%
EPS(NY)2.02
Fwd EY13.39%
FCF(TTM)0.42
FCFY2.81%
OCF(TTM)0.64
OCFY4.25%
SpS2.3
BVpS3.37
TBVpS3.37
PEG (NY)0.18
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.91% | ||
| ROE | 6.14% | ||
| ROCE | 2.25% | ||
| ROIC | 1.9% | ||
| ROICexc | 13.5% | ||
| ROICexgc | 13.5% | ||
| OM | 4.32% | ||
| PM (TTM) | 9.01% | ||
| GM | 74.51% | ||
| FCFM | 18.43% |
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
F-Score6
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 0.69 | ||
| Debt/EBITDA | 1.28 | ||
| Cap/Depr | 223.14% | ||
| Cap/Sales | 9.47% | ||
| Interest Coverage | 8.86 | ||
| Cash Conversion | 325.76% | ||
| Profit Quality | 204.52% | ||
| Current Ratio | 5.03 | ||
| Quick Ratio | 4.75 | ||
| Altman-Z | 4.71 |
F-Score6
WACC8.76%
ROIC/WACC0.22
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1178.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%141.89%
EPS Next Y58.83%
EPS Next 2Y52.73%
EPS Next 3Y54.94%
EPS Next 5YN/A
Revenue 1Y (TTM)29.04%
Revenue growth 3Y11.41%
Revenue growth 5Y12.17%
Sales Q2Q%21.26%
Revenue Next Year15%
Revenue Next 2Y18.5%
Revenue Next 3Y19.29%
Revenue Next 5YN/A
EBIT growth 1Y256.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-6.6%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y177.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y217.63%
OCF growth 3Y127.03%
OCF growth 5YN/A